| (SEK) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -32.19M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ONCO.ST returned -58.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -65.8% |
| 1 year | -58.3% |
| 5 years | -96.8% |
| All-time high | kr 185.80 (Nov 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in ONCO.ST would be worth today ›No. Oncopeptides AB (publ) has not paid a dividend in the past 12 months.
Oncopeptides AB (publ) is part of the Healthcare sector.
Oncopeptides AB (publ) has a market cap of 627.33M SEK, based on the latest quote.
Oncopeptides AB (publ) is scheduled to report earnings on Aug 27, 2026.
